Contact

Jiangsu Maslech Medical Technology Co., Ltd.

Address: Building G39, North Side of Xinyang Road & East Side of Koutai Road , China Medical City , Taizhou City, Jiangsu Province, China

Tel£º400-0523-167

Fax:£º400-0523-167

Email£ºservice@china-maslech.com

Search
location£ºhome > News > CompanyNews

How spotted trends bring new medical reform industry

2014-8-14 10:18:50Click on the£º
 

Opinions on the new health care reform is deepening medical and health system of the CPC Central Committee, the State Council announced to the community. "Opinion" proposed "effectively reduce the burden of medical costs residents, effectively alleviate the 'medical treatment is difficult and expensive,'" the short-term goal, and "establish and improve urban and rural residents covered by basic medical and health system to provide people with safe, effective, convenient and price Lim's medical and health services, "the long-term goal.

What would change the new health care reform is? What has changed?  companies that live in health reform wave pharmaceutical, how the new health reform trends spotted brought for industry, the flow, a firm foothold in the market it?

In the new health care reform process, the main purpose is to solve the "difficult and expensive," the short-term goal, a senior marketing consultant in dui rui kang Beijing management consulting firm ,Liu shuang cutting-edge in the twelfth China Pharmaceutical Marketing Forum April 26 in said: "The more bluntly, to solve difficult and that is to strengthen the reform of public hospitals; solve expensive, it is the basic drug system reform which inevitably spawned a series of changes in the pharmaceutical industry.."

Change one: to increase the concentration of drugs in circulation Liu frost analysis pointed out that medical treatment is difficult to solve the problem is "a drop five liters," but no matter how down, how l, gave birth to is "secondary bargain", the second bargaining mainly by commercial companies to carry out, while the second bargaining direct victim of industrial enterprises. Meanwhile, cancel drug medication increases dramatically change the structure of the hospital, the hospital will increase the expensive drug control, does not condone previous sales model, but if in the second bargaining premise, it will release the control of high-priced drugs clear attitude ultimate beneficiaries are the hospital, but for the second part of the bargain, there is no relevant countries.

It is noteworthy that the development of county-level hospitals and essential drugs released for channel effects. Liu frost noted that the current requirements of the development of county hospitals is to achieve "no serious illness County," which would significantly longer payment cycles, sometimes once a year money, perhaps even because of different levels of development of the region's emergence as like Jilin can not get back to the case of two models, the slow payment will become an important factor restricting the channel. Meanwhile, the provinces of essential drugs will change the model of the original publication channel, the length will be longer, wider width, but also the appropriate breadth of coverage, which could lead to channel blending of the problem, in this reality, the original the model must be changed to consider covering hospitals, clinics, pharmacies and other diversified model.

In the process of reform of basic drug system, the pharmaceutical distribution industry will be changed dramatically, the future of the pharmaceutical distribution industry concentration will show a geometric increase in the concentration of a significant increase in circulation, small and medium circulation enterprises will be further reduced because Village integration and other channels will be stretched, increasing the coverage ratio requirements for security, while the channel widened stretch will become an irreversible trend. Changes in two: the pharmaceutical industry shrinking profit margins significantly Another noteworthy point is that the pharmaceutical industry will move toward "profit-oriented." Liu frost analysis, profit-oriented focus is reflected in three aspects, namely, the "pressure of industrial enterprises compression channels cost increases, the pressure of industrial enterprises increased accounts receivable, payment cycle pressure industrial enterprises increased." Specific analysis is concerned, in 2012, the National Development and Reform Commission conducted two significant reduction in drug prices, mainly related to digestion, anti-tumor, immune and blood products, drug prices lead to drug circulation margins are compressed; meanwhile, commitment at all levels of hospital drug payment time period continued to deteriorate, and the medical institutions owed money for too long the drug wholesale business problem is further exacerbated by the survival and development of enterprises to further squeeze profit of the operating characteristics of the pharmaceutical industry is becoming increasingly apparent. Changes in two: the pharmaceutical industry shrinking profit margins significantly Another noteworthy point is that the pharmaceutical industry will move toward "profit-oriented." Liu frost analysis, profit-oriented focus is reflected in three aspects, namely, the "pressure of industrial enterprises compression channels cost increases, the pressure of industrial enterprises increased accounts receivable, payment cycle pressure industrial enterprises increased." Specific analysis is concerned, in 2012, the National Development and Reform Commission conducted two significant reduction in drug prices, mainly related to digestion, anti-tumor, immune and blood products, drug prices lead to drug circulation margins are compressed; meanwhile, commitment at all levels of hospital drug payment time period continued to deteriorate, and the medical institutions owed money for too long the drug wholesale business problem is further exacerbated by the survival and development of enterprises to further squeeze profit of the operating characteristics of the pharmaceutical industry is becoming increasingly apparent.

Changes in two: the pharmaceutical industry shrinking profit margins significantly Another noteworthy point is that the pharmaceutical industry will move toward "profit-oriented." Liu frost analysis, profit-oriented focus is reflected in three aspects, namely, the "pressure of industrial enterprises compression channels cost increases, the pressure of industrial enterprises increased accounts receivable, payment cycle pressure industrial enterprises increased." Specific analysis is concerned, in 2012, the National Development and Reform Commission conducted two significant reduction in drug prices, mainly related to digestion, anti-tumor, immune and blood products, drug prices lead to drug circulation margins are compressed; meanwhile, commitment at all levels of hospital drug payment time period continued to deteriorate, and the medical institutions owed money for too long the drug wholesale business problem is further exacerbated by the survival and development of enterprises to further squeeze profit of the operating characteristics of the pharmaceutical industry is becoming increasingly apparent.

Three changes: changes in the structure of the future of the pharmaceutical channel Tilt the county public hospital health care reform is bound to change in the future pharmaceutical channel structure. From a clinical point of view format, three channels, two channels will tend to reduce the links, increase profits; Judging from retailing to three main channels, two channels, supplemented by selective channels from over to intensive ; drug format from the base point of view, the main city in the secondary channels, mainly rural with three channels from a single type of channel over to select type channels; format from generic drugs, the provincial to the three main channels, area dominated by two channels, channels are intensive, emphasizing terminal coverage and security for rate. The new medical reform policy in principle unchanged, guiding policy adjustments, the pharmaceutical market need to do is to actively respond to policy changes brought about by changes in the market, flexibility to adjust the channel model, timely alternative development strategy, and to consider new ways of marketing, dominate the market instead of being out of the market.